Charles River Laboratories announces new tumour model compendium
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
List view / Grid view
The Compendium provides scientists an online resource to help design efficient in vitro and in vivo oncology research studies.
Scientists have shown that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by MS...
Researchers propose a novel approach to manipulate genes that may hold the key to the future of personalised medicine...
Using Raman optical technology, scientists can now produce images of brain tissue that is affected by Alzheimer’s disease...
A new protocol could be a step toward stem cell-based therapies to restore sensation in people who have lost feeling in parts of their body...
Amplifying patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies...
Researchers have identified a promising solution to improving treatments offered to patients with cystic fibrosis that could lead to the development of new personalised therapies...
Next generation sequencing sample preparation on the KingFisher platform...
A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
A debate on the impact of PFS regulation at Pre-Filled Syringes 2018...
Scientists have identified new biomarkers that could help more accurately classify the two main subtypes of hepatoblastoma...
An antibody treatment has been found to reduce the rate of flare-ups by nearly 20 percent in patients with a subgroup of treatment-resistant COPD...
A research team have studied how alterations in a tumour depend on each other and how these dependencies determine cancer evolution...
AMI has released the full version of HCC Coding as part of the EMscribe suite of tools in support of medical records processing and abstraction.
Scientists have armed immune cells with a new surface molecule that causes them to respond aggressively when they encounter a protein that tumours actually use to camouflage themselves from the immune system. Researchers from the Helmholtz Zentrum München and various partners introduced the method in ‘Cancer Research’.